CSIMarket
 
Cannapharmarx Inc   (CPMD)
 

Cannapharmarx Inc's Suppliers Performance

CPMD's Supply Chain




 
CPMD Costs vs Sales of Suppliers Growth Cannapharmarx Inc's cost of sales deteriorated by -51.38 % year on year, sequentially cost of sales grew by 33.1 % in Q2.

More on CPMD Suppliers



Cannapharmarx Inc's cost of sales deteriorated by -51.38 % year on year, sequentially cost of sales grew by 33.1 % in Q2.

More on CPMD Suppliers




Cannapharmarx Inc's Comment on Supply Chain


The sourcing of raw materials, manufacturing, packaging, and distribution processes must comply with IMCA standards, ensuring strict control and supervision. Each stage, from breeding to finished product distribution through pharmacies, requires maintaining optimal environmental conditions and standardized procedures. Regular analytical examinations are conducted to verify quality compliance. Pharmacies selling medical cannabis must obtain a dedicated license from the IMCA and adhere to regulations set by the Ministry of Health (MOH), local municipalities, and district pharmacists, including security and storage protocols. Additionally, pharmacies must hold a Good Distribution Practice (GDP) license from the IMCA, permitting only certified cannabis pharmacists to sell and advise on cannabis products. Transportation of medical cannabis requires a transport license from the IMCA and compliance with GDP and Good Security Practice (GSP) standards, with security measures adjusted based on shipment size and destination. The export and import of pharmaceutical-grade cannabis are regulated by the Narcotics Convention, an international treaty overseeing narcotic drugs under license for medical and research purposes.

Cannapharmarx Inc's Comment on Supply Chain


The sourcing of raw materials, manufacturing, packaging, and distribution processes must comply with IMCA standards, ensuring strict control and supervision. Each stage, from breeding to finished product distribution through pharmacies, requires maintaining optimal environmental conditions and standardized procedures. Regular analytical examinations are conducted to verify quality compliance. Pharmacies selling medical cannabis must obtain a dedicated license from the IMCA and adhere to regulations set by the Ministry of Health (MOH), local municipalities, and district pharmacists, including security and storage protocols. Additionally, pharmacies must hold a Good Distribution Practice (GDP) license from the IMCA, permitting only certified cannabis pharmacists to sell and advise on cannabis products. Transportation of medical cannabis requires a transport license from the IMCA and compliance with GDP and Good Security Practice (GSP) standards, with security measures adjusted based on shipment size and destination. The export and import of pharmaceutical-grade cannabis are regulated by the Narcotics Convention, an international treaty overseeing narcotic drugs under license for medical and research purposes.







CPMD's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Cannapharmarx Inc 1.36 1.70 -11.32 26
SUBTOTAL 0.00 0.00 0.00 -


Sources: Cannapharmarx Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Cannapharmarx Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.